Tatva Chintan Pharma Chem Q2 Results
- BSE: 543321
- NSE: TATVA
- ISIN: INE0GK401011
- Sector: Chemical Manufacturing
BSE
822
-1.00 (-0.12%)
-1.00 (-0.12%)Volume1.11 K
Updated: Mon 25 Nov, 2024 | 15:28:49
NSE
825
0.40 (0.05%)
0.40 (0.05%)Volume14.92 K
Updated: Mon 25 Nov, 2024 | 15:29:58
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹83.49 Cr.(-20.84%)
- Operating Profit₹-1.23 Cr.(NA%)
- Profit After Tax₹-0.66 Cr.(NA%)
- Operating Margin-1.47%(NA%)
Note: Comparison is on YoY basis
Quarterly - Tatva Chintan Pharma Chem Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 83.49 | 114.36 | -% | 96.67 | -% |
| Selling/ General/ Admin Expenses Total | 12.94 | 11.56 | -% | 14.07 | -% |
| Depreciation/ Amortization | 6.81 | 6.01 | -% | 6.78 | -% |
| Other Operating Expenses Total | 22.24 | 23.41 | -% | 25.04 | -% |
| Total Operating Expense | 84.72 | 99.03 | -% | 83.20 | -% |
| Operating Income | -1.23 | 15.33 | -% | 13.47 | -% |
| Net Income Before Taxes | -1.02 | 13.42 | -% | 11.21 | -% |
| Net Income | -0.66 | 9.50 | -% | 7.78 | -% |
| Diluted Normalized EPS | -0.29 | 4.29 | -% | 3.43 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST - Markets
02C2C Advanced Systems IPO Day 2: Check GMP, subscription status and other key details
2 min read06:59 PM IST - Markets
03Stocks to buy or sell: Dharmesh Shah of ICICI Securities recommends buying L&T, Syngene International on November 25
5 min read10:00 AM IST